Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma
- PMID: 12899729
- DOI: 10.1046/j.1365-2141.2003.04478.x
Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma
Comment in
-
Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation.Br J Haematol. 2003 Nov;123(4):746-7. doi: 10.1046/j.1365-2141.2003.04675.x. Br J Haematol. 2003. PMID: 14616983 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
